Get the Stockscreener App
140.18
0.07%
0.10
After Hours:
160.00
19.82
+14.14%
Irhythm Technologies Inc stock is traded at $140.18, with a volume of 859.79K.
It is up +0.07% in the last 24 hours and down -8.95% over the past month.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$140.08
Open:
$140.08
24h Volume:
859.79K
Relative Volume:
1.69
Market Cap:
$4.48B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-28.84
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
+5.96%
1M Performance:
-8.95%
6M Performance:
+28.78%
1Y Performance:
+62.53%
1-Day Range:
$137.60
$142.03
1-Week Range:
$132.28
$142.56
52-Week Range:
$55.92
$157.13
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
140.18 | 4.47B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
IRhythm Technologies Grows Sales Quickly But Profit Remains Elusive - Finimize
iRhythm Technologies Reports Strong Q2 2025 Growth - TipRanks
Decoding iRhythm Technologies Inc (IRTC): A Strategic SWOT Insig - GuruFocus
iRhythm Technologies (IRTC) Reports Strong Q2 2025 Results - GuruFocus
Earnings call transcript: iRhythm beats Q2 2025 forecasts with strong revenue growth - Investing.com
iRhythm Technologies surges 13.4% as Q2 earnings beat expectations By Investing.com - Investing.com India
iRhythm Technologies surges 13.4% as Q2 earnings beat expectations - Investing.com
iRhythm Technologies, Inc. SEC 10-Q Report - TradingView
iRhythm Tech earnings beat by $0.19, revenue topped estimates - Investing.com Canada
iRhythm (NASDAQ:IRTC) Delivers Strong Q2 Numbers, Stock Soars - TradingView
IRhythm Technologies Q2 revenue beats estimates - MarketScreener
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions - The Manila Times
iRhythm Technologies Announces Second Quarter 2025 Financial Results - The Manila Times
What is the dividend policy of iRhythm Technologies Inc. stockFinancial News Data Feed With High Returns - jammulinksnews.com
How does iRhythm Technologies Inc. generate profit in a changing economyEarnings Report Insights To Watch Now - jammulinksnews.com
FDA Clearance Boosts iRhythm Zio Device Innovation and Fuels Growth Potential - Insider Monkey
iRhythm Technologies Inc. Stock Flags Risk Zone in Volatility IndexProven Entry Plan With Low Risk Shared - metal.it
iRhythm Technologies Earnings Announcement: What to ExpectNews and Statistics - IndexBox
iRhythm Technologies (IRTC): Assessing Earnings Outlook and Catalysts for Q2 2025 - AInvest
What To Expect From iRhythm’s (IRTC) Q2 Earnings - Yahoo Finance
Published on: 2025-07-29 06:26:10 - metal.it
iRhythm Technologies IRTC Q2 2025 Earnings Preview Upside Anticipated from Strong Revenue Growth - AInvest
What institutional investors are buying iRhythm Technologies Inc. stockAdvanced Screener Target Finder With High Returns - jammulinksnews.com
How strong is iRhythm Technologies Inc. company’s balance sheetTop Growth Opportunities For Fast Growth - jammulinksnews.com
What are iRhythm Technologies Inc. company’s key revenue driversMaximize gains with strategic stock entries - jammulinksnews.com
How many analysts rate iRhythm Technologies Inc. as a “Buy”Capitalize on fast-moving market trends - jammulinksnews.com
Is iRhythm Technologies Inc. a growth stock or a value stockMaximize returns with expert trading insights - jammulinksnews.com
Does iRhythm Technologies Inc. stock perform well during market downturnsSuperior profit margins - jammulinksnews.com
What catalysts could drive iRhythm Technologies Inc. stock higher in 2025Record-breaking gains - jammulinksnews.com
What is the risk reward ratio of investing in iRhythm Technologies Inc. stockFree Investment Portfolio Suggestions - jammulinksnews.com
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc.IRTC - Business Wire
What analysts say about iRhythm Technologies Inc. stockSuperior capital gains - PrintWeekIndia
iRhythm Technologies Inc. Stock Analysis and ForecastSkyrocketing investment returns - PrintWeekIndia
What makes iRhythm Technologies Inc. stock attractive to long term investorsExceptional earning trajectories - jammulinksnews.com
Earnings Preview: IRTC to Report Financial Results Post-market on July 31 - 富途牛牛
P 500Game-changing returns - jammulinksnews.com
Is iRhythm Technologies Inc. a good long term investmentBreakthrough profits - PrintWeekIndia
SHAREHOLDER ALERT: Morris Kandinov Investigating AVDX, - GlobeNewswire
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
What drives iRhythm Technologies Inc. stock pricePhenomenal returns - Autocar Professional
Tempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum - Nasdaq
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):